Combining CXCR4-targeted and nontargeted nanoparticles for effective unassisted in vitro magnetic hyperthermia: Biointerphases: Vol 13, No 1

Abstract

The use of targeted nanoparticles for magnetic hyperthermia (MHT) increases MHT selectivity, but often at the expense of its effectiveness. Consequently, targeted MHT is typically used in combination with other treatment modalities. This work describes an implementation of a highly effective monotherapeutic in vitro MHT treatment based on two populations of magnetic particles. Cells were sequentially incubated with two populations of magnetic particles: nonfunctionalized superparamagnetic nanoparticles and anti-CXCR4-functionalized particles. After removing the excess of free particles, an alternating magnetic field (AMF) was applied to produce MHT. The induced cytotoxicity was assessed at different time-points after AMF application. Complete loss of cell viability was observed 72 h after MHT when the iron loading of the anti-CXCR4-functionalized particles was boosted by that of a nontargeted population. Additionally, induction of necrosis resulted in more efficient cell death than did induction of apoptosis. Achieving a uniquely high effectiveness in monotherapeutic MHT demonstrates the potential of this approach to achieve complete loss of viability of cancer cells while avoiding the side effects of dual-treatment strategies that use MHT only as a sensitizing therapy.

References

1. M. Banobre-Lopez, A. Teijeiro, and J. Rivas, Rep. Pract. Oncol. Radiother. 18, 397 (2013). https://doi.org/10.1016/j.rpor.2013.09.011, Google ScholarCrossref
2. B. Hildebrandt, P. Wust, O. Ahlers, A. Dieing, G. Sreenivasa, T. Kerner, R. Felix, and H. Riess, Crit. Rev. Oncol. Hematol. 43, 33 (2002). https://doi.org/10.1016/S1040-8428(01)00179-2, Google ScholarCrossref
3. R. T. Gordon, J. R. Hines, and D. Gordon, Med. Hypotheses 5, 83 (1979). https://doi.org/10.1016/0306-9877(79)90063-X, Google ScholarCrossref, CAS
4. Y. Rabin, Int. J. Hyperthermia 18, 194 (2002). https://doi.org/10.1080/02656730110116713, Google ScholarCrossref, CAS
5. A. M. Kruse, S. A. Meenach, K. W. Anderson, and J. Z. Hilt, Acta Biomater. 10, 2622 (2014). https://doi.org/10.1016/j.actbio.2014.01.025, Google ScholarCrossref, CAS
6. S. H. Liao, C. H. Liu, B. P. Bastakoti, N. Suzuki, Y. Chang, Y. Yamauchi, F. H. Lin, and K. C. Wu, Int. J. Nanomed. 10, 3315 (2015) https://doi.org/10.2147/IJN.S68719. Google ScholarCrossref, CAS
7. S. Sadhasivam, S. Savitha, C. J. Wu, F. H. Lin, and L. Stobinski, Int. J. Pharm. 480, 8 (2015). https://doi.org/10.1016/j.ijpharm.2015.01.029, Google ScholarCrossref, CAS
8. T. Sadhukha, T. S. Wiedmann, and J. Panyam, Biomaterials 34, 5163 (2013). https://doi.org/10.1016/j.biomaterials.2013.03.061, Google ScholarCrossref, CAS
9. J. Zhang, A. H. Dewilde, P. Chinn, A. Foreman, S. Barry, D. Kanne, and S. J. Braunhut, Int. J. Hyperthermia 27, 682 (2011). https://doi.org/10.3109/02656736.2011.609863, Google ScholarCrossref
10. O. K. Arriortua et al., Beilstein J. Nanotechnol. 7, 1532 (2016). https://doi.org/10.3762/bjnano.7.147, Google ScholarCrossref, CAS
11. A. Espinosa, R. Di Corato, J. Kolosnjaj-Tabi, P. Flaud, T. Pellegrino, and C. Wilhelm, ACS Nano 10, 2436 (2016). https://doi.org/10.1021/acsnano.5b07249, Google ScholarCrossref, CAS
12. A. Hervault, A. E. Dunn, M. Lim, C. Boyer, D. Mott, S. Maenosono, and N. T. Thanh, Nanoscale 8, 12152 (2016). https://doi.org/10.1039/C5NR07773G, Google ScholarCrossref, CAS
13. B. P. Shah, N. Pasquale, G. De, T. Tan, J. Ma, and K. B. Lee, ACS Nano 8, 9379 (2014). https://doi.org/10.1021/nn503431x, Google ScholarCrossref, CAS
14. P. T. Yin, B. P. Shah, and K. B. Lee, Small 10, 4106 (2014) https://doi.org/10.1002/smll.201400963. Google ScholarCrossref, CAS
15. C. Yuan, Y. An, J. Zhang, H. Li, H. Zhang, L. Wang, and D. Zhang, Nanotechnology 25, 345101 (2014). https://doi.org/10.1088/0957-4484/25/34/345101, Google ScholarCrossref
16. K. Maier-Hauff, F. Ulrich, D. Nestler, H. Niehoff, P. Wust, B. Thiesen, H. Orawa, V. Budach, and A. Jordan, J. Neurooncol. 103, 317 (2011). https://doi.org/10.1007/s11060-010-0389-0, Google ScholarCrossref
17. D. H. Kim, Y. Guo, Z. L. Zhang, D. Procissi, J. Nicolai, R. A. Omary, and A. C. Larson, Adv. Healthcare Mater. 3, 714 (2014). https://doi.org/10.1002/adhm.201300209, Google ScholarCrossref, CAS
18. H. C. Kim, E. Kim, S. W. Jeong, T. L. Ha, S. I. Park, S. G. Lee, S. J. Lee, and S. W. Lee, Nanoscale 7, 16470 (2015). https://doi.org/10.1039/C5NR04130A, Google ScholarCrossref, CAS
19. C. A. Quinto, P. Mohindra, S. Tong, and G. Bao, Nanoscale 7, 12728 (2015). https://doi.org/10.1039/C5NR02718G, Google ScholarCrossref, CAS
20. V. Vilas-Boas, R. Silva, A. R. Gaio, A. M. Martins, S. C. Lima, A. Cordeiro-da-Silva, M. de Lourdes Bastos, and F. Remiao, Cytometry A 79, 912 (2011). https://doi.org/10.1002/cyto.a.21135, Google ScholarCrossref
21. Y. V. Kolen'ko et al., J. Phys. Chem. C 118, 8691 (2014). https://doi.org/10.1021/jp500816u, Google ScholarCrossref
22. M. Hedayati et al., Nanomedicine 8, 29 (2013). https://doi.org/10.2217/nnm.12.98, Google ScholarCrossref, CAS
23. S. Fraga et al., J. Appl. Toxicol. 33, 1111 (2013). https://doi.org/10.1002/jat.2865, Google ScholarCrossref, CAS
24. G. Koopman, C. P. Reutelingsperger, G. A. Kuijten, R. M. Keehnen, S. T. Pals, and M. H. van Oers, Blood 84, 1415 (1994), available at http://www.bloodjournal.org/content/84/5/1415. Google ScholarCAS
25. M. J. Valente, R. Henrique, V. Vilas-Boas, R. Silva, L. Bastos Mde, F. Carvalho, P. Guedes de Pinho, and M. Carvalho, Arch. Toxicol. 86, 249 (2012). https://doi.org/10.1007/s00204-011-0749-3, Google ScholarCrossref, CAS
26. D. J. Barbosa, J. P. Capela, R. Silva, V. Vilas-Boas, L. M. Ferreira, P. S. Branco, E. Fernandes, L. Bastos Mde, and F. Carvalho, Arch. Toxicol. 88, 455 (2014). https://doi.org/10.1007/s00204-013-1120-7, Google ScholarCrossref, CAS
27. A. Muela, D. Munoz, R. Martin-Rodriguez, I. Orue, E. Garaio, A. A. D. de Cerio, J. Alonso, J. A. Garcia, and M. L. Fdez-Gubieda, J. Phys. Chem. C 120, 24437 (2016). https://doi.org/10.1021/acs.jpcc.6b07321, Google ScholarCrossref, CAS
28. M. Poirier, J. C. Simard, F. Antoine, and D. Girard, J. Appl. Toxicol. 34, 404 (2014). https://doi.org/10.1002/jat.2956, Google ScholarCrossref, CAS
29. S. Dutz and R. Hergt, Nanotechnology 25, 452001 (2014). https://doi.org/10.1088/0957-4484/25/45/452001, Google ScholarCrossref
30. A. J. Ullal and D. S. Pisetsky, Apoptosis 15, 586 (2010). https://doi.org/10.1007/s10495-010-0470-3, Google ScholarCrossref, CAS
31. N. Lee, D. Yoo, D. Ling, M. H. Cho, T. Hyeon, and J. Cheon, Chem. Rev. 115, 10637 (2015). https://doi.org/10.1021/acs.chemrev.5b00112, Google ScholarCrossref, CAS
32. S. Y. Proskuryakov, A. G. Konoplyannikov, and V. L. Gabai, Exp. Cell Res. 283, 1 (2003). https://doi.org/10.1016/S0014-4827(02)00027-7, Google ScholarCrossref, CAS
33. S. Toraya-Brown et al., Nanomedicine 10, 1273 (2014). https://doi.org/10.1016/j.nano.2014.01.011, Google ScholarCrossref, CAS
34. P. Guardia, R. Di Corato, L. Lartigue, C. Wilhelm, A. Espinosa, M. Garcia-Hernandez, F. Gazeau, L. Manna, and T. Pellegrino, ACS Nano 6, 3080 (2012). https://doi.org/10.1021/nn2048137, Google ScholarCrossref, CAS
35. K. Hayashi, M. Nakamura, W. Sakamoto, T. Yogo, H. Miki, S. Ozaki, M. Abe, T. Matsumoto, and K. Ishimura, Theranostics 3, 366 (2013). https://doi.org/10.7150/thno.5860, Google ScholarCrossref, CAS
36. A. J. Giustini, R. E. Gottesman, A. A. Petryk, A. M. Rauwerdink, and P. J. Hoopes, Proc SPIE 7901, 790118 (2011) https://doi.org/10.1117/12.876519. Google ScholarCrossref
37. F. Baribaud et al., J. Virol. 75, 8957 (2001). https://doi.org/10.1128/JVI.75.19.8957-8967.2001, Google ScholarCrossref, CAS
38. N. Guldris et al., Bioconjugate Chem. 28, 362 (2017). https://doi.org/10.1021/acs.bioconjchem.6b00522, Google ScholarCrossref, CAS
39. M. Ma, Y. Zhang, X. L. Shen, J. Xie, Y. Li, and N. Gu, Nano Res. 8, 600 (2015). https://doi.org/10.1007/s12274-015-0729-7, Google ScholarCrossref, CAS
40. M. N. Centelles, M. Wright, W. Gedroyc, and M. Thanou, Pharmacol. Res. 114, 144 (2016). https://doi.org/10.1016/j.phrs.2016.10.017, Google ScholarCrossref, CAS
41. X. L. Liu et al., Adv. Healthcare Mater. 5, 2092 (2016). https://doi.org/10.1002/adhm.201600357, Google ScholarCrossref, CAS
42. See supplementary material at https://doi.org/10.1116/1.5009989 E-BJIOBN-13-309801 for additional supporting material for this manuscript is available free of charge: PBMC isolation protocol, comparison between JK cells and PBMC concerning CXCR4 targeting, cell–nanoparticle interaction followed by flow cytometry changes in SSC, cytotoxicity induced by using each type of nanoparticles separately, and optimization of AMF parameters. Google Scholar
Published by the AVS.

Article Metrics

Views

333

Citations

Crossref 0

Web of Science

ISI 1